Leadership Team

The People Behind NovaPharm Healthcare

Our executive team brings together decades of pharmaceutical industry experience across regulatory compliance, supply chain operations, formulation science, and clinical safety — united by a commitment to delivering GDP-compliant, MHRA-regulated medicines to patients across the UK.

Executive Leadership

Our Executive Team

Industry leaders with direct responsibility for regulatory compliance, commercial operations, scientific governance, and clinical safety at NovaPharm Healthcare.

Vishal Om Prakash Chakravarty — Founder and CEO of NovaPharm Healthcare Ltd

Vishal Om Prakash Chakravarty

Chief Executive Officer

Pharmaceutical entrepreneur NovaPharm Healthcare Ltd. Brings deep expertise in MHRA PLPI licensing, EU-GMP supplier qualification, and pharmaceutical market access across the UK and European Union. Leads the company's strategic vision, commercial partnerships, and regulatory programme — with a particular focus on high-value therapeutic categories.

PLPI Licensing EU-GMP Sourcing Market Access Oncology Regulatory Strategy
Prabhakar Vitthal Lahare — Chief Operations Officer of NovaPharm Healthcare Ltd

Prabhakar Vitthal Lahare

Chief Operations Officer

27+ years of pharmaceutical operations experience, including 18+ years in senior leadership. Oversees global supply chain architecture, Quality Management Systems (QMS), and operational excellence across MHRA, EU, USFDA, and TGA regulatory jurisdictions. Brings a proven track record in GDP-compliant distribution and multi-territory manufacturing oversight.

Supply Chain QMS USFDA TGA GDP Operations
Dr. Girish Shantilal Achliya — Chief Scientific Officer of NovaPharm Healthcare Ltd

Dr. Girish Shantilal Achliya

Chief Scientific Officer

M.Pharm, PhD, JD. 25+ years of pharmaceutical innovation with an extensive portfolio of 40+ patent inventions. Leads formulation development, regulatory submissions, GMP compliance, and portfolio strategy at NovaPharm Healthcare. Combines deep scientific expertise with legal and IP acumen to drive product pipeline and regulatory approvals.

Formulation 40+ Patents GMP Compliance Regulatory Submissions IP Strategy

Dr. Helly Kamlesh Panchal

Medical Advisor

MD and Pharmacovigilance Specialist responsible for ensuring clinical safety and efficacy standards across all NovaPharm Healthcare products and operations. Leads the company's pharmacovigilance protocols, including MHRA Yellow Card integration, adverse event management, and 24/7 on-call escalation — ensuring full compliance with UK and EU patient safety requirements.

Pharmacovigilance Clinical Safety Adverse Events MHRA Yellow Card

Governance & Verification: All leadership credentials, including Qualified Person (QP) certifications and regulatory authorisations, are subject to formal verification. Full documentation is available on request. Contact: vishal@novapharmhealthcare.com

Regulatory Framework

Compliance & Corporate Governance

NovaPharm Healthcare operates under full Companies House registration and MHRA regulatory oversight. All directorship positions are subject to statutory filings, regulatory audit, and ongoing compliance obligations.

Corporate Registration

NovaPharm Healthcare Ltd is incorporated in England and Wales and is subject to all applicable Companies Act obligations. Director information is publicly available via Companies House.

Companies House Number 16716501
Company Type Private Limited Company
Incorporated England & Wales
Registered Office Flat 72 Archer Court, 21 High Street,
Feltham, London TW13 4AG, UK

View on Companies House →

Regulatory Status

NovaPharm Healthcare operates under MHRA oversight and is committed to full GDP compliance across all distribution operations.

MHRA WDA(H) Application in Progress
Distribution Standard GDP Compliant — EU-GMP Verified Network
Pharmacovigilance MHRA Yellow Card Integrated

Full regulatory documentation available to qualified customers and audit bodies on request via vishal@novapharmhealthcare.com.

Want to Work with Our Team?

Get in touch to discuss pharmaceutical sourcing, PLPI licensing, supply partnerships, or any regulatory enquiries.